# Scandinavian Intensive Care Unit (ICU) Glutamine Study

> **NCT00922714** · PHASE4 · TERMINATED · sponsor: **Scandinavian Critical Care Trials Group** · enrollment: 1000 (estimated)

## Conditions studied

- ICU Patients

## Interventions

- **DRUG:** Glutamine
- **DRUG:** saline (placebo)

## Key facts

- **NCT ID:** NCT00922714
- **Lead sponsor:** Scandinavian Critical Care Trials Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** 2007-05
- **Final completion:** 2009-08
- **Target enrollment:** 1000 (ESTIMATED)
- **Why stopped:** Slow recruitment, stopped after 4 years
- **Last updated:** 2009-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922714, "Scandinavian Intensive Care Unit (ICU) Glutamine Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00922714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*